Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 10.386 Q1 | 254 | 33 | 59 | 10674 | 1354 | 59 | 21.41 | 323.45 | |
2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.116 Q1 | 82 | 11 | 36 | 2405 | 148 | 36 | 3.39 | 218.64 | |
3 | Medicinal Research Reviews | journal | 3.242 Q1 | 150 | 24 | 83 | 4735 | 864 | 81 | 9.73 | 197.29 | |
4 | Pharmacology and Therapeutics | journal | 3.411 Q1 | 233 | 101 | 299 | 18833 | 3024 | 296 | 9.74 | 186.47 | |
5 | Natural Product Reports | journal | 3.285 Q1 | 211 | 82 | 218 | 15034 | 1973 | 209 | 9.13 | 183.34 | |
6 | Food and Drug Law Journal | journal | 0.322 Q3 | 23 | 25 | 110 | 4417 | 63 | 109 | 0.55 | 176.68 | |
7 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.326 Q1 | 99 | 24 | 80 | 3831 | 424 | 75 | 5.23 | 159.63 | |
8 | Topics in Medicinal Chemistry | book series | 0.108 Q4 | 15 | 8 | 25 | 1218 | 2 | 19 | 0.08 | 152.25 | |
9 | Advances in Pharmacology | journal | 1.058 Q1 | 86 | 30 | 73 | 4440 | 198 | 26 | 2.88 | 148.00 | |
10 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.260 Q3 | 50 | 49 | 86 | 7199 | 57 | 78 | 0.60 | 146.92 | |
11 | Critical Reviews in Toxicology | journal | 1.939 Q1 | 129 | 36 | 125 | 5090 | 716 | 116 | 5.88 | 141.39 | |
12 | Annual Review of Pharmacology and Toxicology | journal | 10.583 Q1 | 224 | 18 | 59 | 2518 | 1415 | 59 | 24.06 | 139.89 | |
13 | Progress in Medicinal Chemistry | journal | 0.962 Q2 | 38 | 6 | 28 | 836 | 61 | 17 | 1.75 | 139.33 | |
14 | Recent Patents on CNS Drug Discovery | journal | 0.672 Q2 | 36 | 17 | 64 | 2366 | 149 | 64 | 2.34 | 139.18 | |
15 | Advanced Drug Delivery Reviews | journal | 4.880 Q1 | 366 | 114 | 406 | 14815 | 6169 | 359 | 11.76 | 129.96 | |
16 | Current Molecular Pharmacology | journal | 1.689 Q1 | 49 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | |
17 | Expert Opinion on Emerging Drugs | journal | 0.973 Q2 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 | |
18 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.997 Q1 | 52 | 33 | 70 | 4134 | 212 | 70 | 3.40 | 125.27 | |
19 | Current Medicinal Chemistry | journal | 1.699 Q1 | 202 | 430 | 828 | 53487 | 4696 | 823 | 5.48 | 124.39 | |
20 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 18 | 59 | 2216 | 175 | 59 | 2.73 | 123.11 | ||
21 | Current Gene Therapy | journal | 1.347 Q1 | 80 | 50 | 132 | 6077 | 671 | 123 | 3.90 | 121.54 | |
22 | Current Pharmaceutical Design | journal | 1.414 Q1 | 183 | 405 | 1128 | 48213 | 4871 | 1016 | 4.21 | 119.04 | |
23 | Drug Resistance Updates | journal | 4.917 Q1 | 132 | 27 | 51 | 3149 | 625 | 50 | 10.57 | 116.63 | |
24 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 8 | 22 | 911 | 0 | 22 | 0.00 | 113.88 | ||
25 | Handbook of Experimental Pharmacology | journal | 1.759 Q1 | 110 | 131 | 364 | 14869 | 1764 | 337 | 5.33 | 113.50 | |
26 | Current Drug Targets | journal | 1.461 Q1 | 119 | 193 | 419 | 21891 | 1600 | 379 | 3.72 | 113.42 | |
27 | Nanotechnology, Science and Applications | journal | 0.274 Q2 | 35 | 10 | 17 | 1114 | 24 | 17 | 1.41 | 111.40 | |
28 | Drug Metabolism Reviews | journal | 1.395 Q1 | 108 | 38 | 89 | 4163 | 449 | 85 | 5.00 | 109.55 | |
29 | CNS and Neurological Disorders - Drug Targets | journal | 1.468 Q1 | 96 | 99 | 188 | 10725 | 777 | 168 | 4.07 | 108.33 | |
30 | Current Topics in Medicinal Chemistry | journal | 1.351 Q1 | 133 | 229 | 445 | 24674 | 1905 | 377 | 3.84 | 107.75 | |
31 | Current Vascular Pharmacology | journal | 0.944 Q2 | 69 | 74 | 182 | 7940 | 580 | 169 | 3.21 | 107.30 | |
32 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 23 | 83 | 2464 | 167 | 83 | 2.11 | 107.13 | ||
33 | Side Effects of Drugs Annual | book series | 0.106 Q4 | 9 | 52 | 157 | 5441 | 4 | 53 | 0.02 | 104.63 | |
34 | Advances in Molecular Toxicology | book series | 0.191 Q3 | 18 | 7 | 24 | 718 | 14 | 20 | 0.44 | 102.57 | |
35 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 14 | 79 | 1436 | 39 | 74 | 0.44 | 102.57 | |
36 | Pharmacogenomics and Personalized Medicine | journal | 0.147 Q4 | 37 | 11 | 20 | 1128 | 9 | 20 | 0.45 | 102.55 | |
37 | Open Nanomedicine Journal | journal | 4 | 5 | 0 | 512 | 0 | 0 | 0.00 | 102.40 | ||
38 | Current Drug Metabolism | journal | 0.993 Q1 | 122 | 98 | 277 | 10022 | 1416 | 259 | 5.17 | 102.27 | |
39 | Expert Opinion on Drug Delivery | journal | 1.689 Q1 | 133 | 111 | 295 | 11234 | 1677 | 290 | 5.70 | 101.21 | |
40 | Infectious Disorders - Drug Targets | journal | 0.778 Q2 | 61 | 48 | 131 | 4761 | 341 | 115 | 2.68 | 99.19 | |
41 | Expert Opinion on Therapeutic Targets | journal | 1.575 Q1 | 106 | 112 | 352 | 10954 | 1340 | 348 | 4.13 | 97.80 | |
42 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.389 Q3 | 30 | 26 | 79 | 2513 | 106 | 79 | 1.27 | 96.65 | |
43 | Current Cancer Drug Targets | journal | 2.137 Q1 | 103 | 94 | 232 | 8928 | 1118 | 220 | 4.78 | 94.98 | |
44 | Expert Opinion on Drug Discovery | journal | 0.621 Q2 | 84 | 92 | 288 | 8715 | 571 | 283 | 2.24 | 94.73 | |
45 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 Q2 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | |
46 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.179 Q3 | 27 | 36 | 111 | 3401 | 43 | 101 | 0.52 | 94.47 | |
47 | Cellular and Molecular Life Sciences | journal | 4.190 Q1 | 261 | 297 | 912 | 27852 | 6861 | 900 | 6.90 | 93.78 | |
48 | Neurotherapeutics | journal | 2.457 Q1 | 136 | 68 | 193 | 6372 | 1459 | 180 | 6.63 | 93.71 | |
49 | Progress in Drug Research | book series | 0.760 Q1 | 46 | 15 | 20 | 1405 | 61 | 18 | 0.00 | 93.67 | |
50 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.018 Q1 | 100 | 120 | 369 | 11161 | 1500 | 365 | 3.53 | 93.01 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®